Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years
Oh, Jiwon, Achiron, Anat, Celius, Elisabeth G., Chambers, Christina, Derwenskus, Joy, Devonshire, Virginia, Hellwig, Kerstin, Hutton, George J., McCombe, Pamela, Moore, Marie, Rog, David, Schneider, JТом:
43
Журнал:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2020.102146
Date:
August, 2020
Файл:
PDF, 1.21 MB
2020
File converter
Більше результатів пошуку
More benefits 
